Readiness To Change HIV/HCV Risk Behavior Among Young African American IDUs. Edward V Morse, PhD, Tulane University Health Sciences Center, Department.

Slides:



Advertisements
Similar presentations
1 Prevalence and Correlates of HIV Risk Behaviors of Inmates in a State Prison System Titilayo Abiona, MD, FMCPH Adedeji Adefuye, MD, MPH, FRIPH Joseph.
Advertisements

Repeat Infections among Adolescents and Young Adults: Findings From Philadelphia STD Clinics Nicole Liddon, PhD 1 Michael Eberhart, BS 2 Jami Leichliter,
Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
The effect of gender specific HIV prevention interventions on heterosexual anal sex among men and women in substance abuse treatment Donald A. Calsyn,
Behavioral Intention and Partner Type on Condom Use Among Men in Drug Treatment Yong S. Song, PhD, University of California, San Francisco Donald Calsyn,
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
A comparison of three different strategies to treat partners of men with urethritis Patty Kissinger 1 Gwangi Richardson-Alston 1 Jami S Leichliter 4 Hamish.
Acknowledgements Methods Veena A. Satyanarayana PhD, Susan Bradford BSEd, Arbi Ben Abdallah DES, Linda B. Cottler PhD, MPH, Washington University School.
High Risk Sharing Behaviors: The Effect of Sex within Injecting Partnerships Meghan D. Morris, PhD, MPH Postdoctoral Research Fellow Department of Epidemiology.
Killing the Pain: Prescription Drug Abuse and Other Risky Behaviors in Rural Appalachia Jennifer R. Havens, PhD, MPH Department of Behavioral Science Center.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
10/16/ Women’s Knowledge, Attitudes, Beliefs and Decisions about HIV/AIDS: A Cross National Comparison.
Race/Ethnicity as a Moderator of HIV/STD Sexual Risk Reduction Groups for Women in Substance Abuse Treatment E. Bell 1, S. Tross 2, A.N.C. Campbell 1,3,
Expanded and Enhanced Treatment Services in a Los Angeles OTP Funded by The Center for Substance Abuse Treatment Targeted Capacity Expansion for Substance.
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
Preventing Medical Complications of Injection Drug Use Keith Heinzerling, MD, MPH UCLA Seminars in Addiction Psychiatry Course August 11, 2005.
Universidad Central del Caribe Comorbidity and HIV Risk Behaviors among Hispanic Drug Users Residing in Puerto Rico Oral Presentation.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
HIV Prevention for Drug-Involved Couples: Gender-Based Approach.
HIV Risk-Reduction: Counselor Training for a Randomized Clinical Trial Louise Haynes 1, Tim Matheson 2, Kathleen Brady 1, Lisa Metsch 3 1 Psychiatry and.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
HIV & HCV Prevention: Intervening at the Prison Gate James A. Inciardi, Daniel J. O’Connell, Hilary L. Surratt, & Steven S. Martin Center for Drug and.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
Introduction Smoking and Social Networks Joseph R. Pruis, Student Research Collaborator, Rosemary A. Jadack, PhD, RN, Professor Department Of Nursing,
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
Increased exposure to an HIV risk reduction protocol associated with a reduction in drug abuse severity Louise F. Haynes 1 ; Rickey E. Carter 1 ; Amy E.
Relationship Power & Sexual Risk in a Sample of Drug-Involved Women Aimee Campbell, MSSW Columbia University School of Social Work Social Intervention.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
How Does Trauma contribute to Substance Abuse and HIV Infection Among Ethnic Women Gail E. Wyatt, Ph.D. Professor, UCLA Department of Psychiatry and Biobehavioral.
Reducing Sex under the Influence for Substance Abuse Treatment Patients Symposium Presentation at the American Psychological Association Annual Convention,
CEACEA CENTROCENTRO DE ESTUDIOS EN ADICCION Testing an Intervention Model to Reduce HIV/AIDS Among Hispanic Drug Users Residing in Puerto Rico Robles RR,
Council for the Advancement of Nursing Conference
D. Hien 1, T. KIlleen 2, A. Campbell 1, H. Jiang 1, E. Nunes 1, 1 Columbia University, New York, NY, USA. 2 Medical University of South Carolina, Charleston,
Effects of Pharmacy Syringe Access Among Young Heroin Injectors Results IDU needle sharing decreased after the enactment of the pharmacy access law in.
Jennifer R. Havens, PhD, MPH Associate Professor
Combined Pharmacological and Behavioral Therapy and HIV Risk Reduction Jennifer Schroeder, David Epstein, Katherine Belendiuk, Jessica Willner-Reid, John.
Factors Predicting Stage of Adoption for Fecal Occult Blood Testing and Colonoscopy among Non-Adherent African Americans Hsiao-Lan Wang, PhD, RN, CMSRN,
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
Introduction Results and Conclusions Comparisons of psychiatric hospitalization rates in the 12 months prior to and after baseline assessment revealed.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Male Sex Workers in Vietnam: Risk Factors & Preliminary Findings from a Sexual Health Intervention.
Marlene Luna Mentor: Britt Rios-Ellis, PhD Department of Health Science California State University, Long Beach HIV / AIDS Latinas.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
Fighting Behavior among early adolescent African Americans: What are the personal and environmental factors? Vanya Jones, PhD, MPH APHA Session ,
High HIV, HBV and HCV Prevalence among People Who Inject Drugs: Results from the First Integrated Bio-behavioral Survey of PWID in Mozambique Authors:
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
Behavioral Health and HIV/HCV Risk Behavior Among Young African American IDUs Patricia M Morse, LCSW, PhD, Edward V, Morse, PhD, Samuel Burgess, MA, MPH.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Trends and Predictors of HIV-Associated Risk Behaviors Among Injecting Drug Users Participating in an HIV Prevention Trial, Bangkok S Vanichseni 1, M Martin.
Melissa A. Lewis, Ph.D. Department of Psychiatry & Behavioral Sciences Center for the Study Health & Risk Behaviors University of Washington Assessing.
PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Kimberly Jeffries Leonard, Ph.D.
Therese Fitzgerald, LCSW, MSW
Mount Sinai School of Medicine
Hatch-Maillette, M. 1, Calsyn, D. A1,2, Doyle, S. 1, Woods, A
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Objective: To examine the relationship between exposure to violence and HIV/HCV high risk-behaviors in a cohort of young African-American IDUs. Of particular.
Conclusions & Implications Table 1: Characteristics of Sample (N=156)
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
Table 1: NHBS HET3 Participant Characteristics
A randomized trial of assessment interventions to reduce drug use and HIV/STI sexual risk among young adults who use drugs in the club scene Steven P.
The Relationship between Recent Alcohol Use and Sexual Behaviors/STDs: Gender Differences among STD Clinic Patients Heidi E. Hutton PhD, Mary E. McCaul.
VACS Scientific Meeting Houston, TX February 2004
Associations Between Feeding Practices and Maternal and Child Weight Among Mothers Who Do Not Correctly Identify Child’s Weight Status Rachel Tabak, PhD,
Expanded and Enhanced Treatment Services in a Los Angeles OTP
Presentation transcript:

Readiness To Change HIV/HCV Risk Behavior Among Young African American IDUs. Edward V Morse, PhD, Tulane University Health Sciences Center, Department of Pediatrics, New Orleans, LA, Patricia M Morse, LCSW, PhD, and Stan Hoogerwerf, MA, LSU Health Sciences Center, Department of Psychiatry New Orleans, LA, Samuel Burgess, MA, MPH Louisiana Office of Public Health

Objective: To examine the differential effects of self-efficacy and self-esteem on stimulating readiness to change HIV/HCV sexual and drug use risk behaviors in a cohort of young African American IDUs participating in a longitudinal study comparing the relative efficacy of three HIV/HCV risk reduction interventions.

Methods: As part of a National Institute on Drug Abuse (NIDA) - funded risk reduction intervention study, 228 young incarcerated African American IDUs were tested for HBV and HCV (Abbott Laboratories) and interviewed using an audio computer- assisted interview schedule (ACASI) designed with Questionnaire Development System (QDS) software. Data collected included participant demographics, high risk injection practices including sharing syringes, cookers, cotton, rinse water, and backloading, high risk sexual behavior practices, as well as measures of readiness to change, self efficacy and self esteem.

Methods: At baseline participants were randomized into one of three intervention arms: CT- Basic counseling and testing arm with pre and post test counseling using a standard CDC protocol PSP- Pharmacy Syringe Purchase– Participants were taught how to purchase syringes at pharmacies (permitted by Louisiana law) without calling attention to themselves and threatening pharmacy personnel CCBI- Brief client centered behavioral intervention using Motivational Interviewing techniques

Methods: Three Measures of Readiness to Change Intention not to Share Syringes Intention to Purchase Syringes at a Pharmacy Intention to use Condoms Each was measured at baseline and 6 month follow-up using an 5 point scale ranging from 1=never to 5=always

Methods: Injection Risk Scale-- measured at baseline and 6 month follow-up. The scale is a summary measure of the dichotomous responses (0=no, 1=yes) to 5 self reported injection risk behaviors (range 0-5; Chronbach’s alpha=.86) Sharing Syringes Sharing Cookers Sharing Rinse Water Sharing Cotton Backloading

Methods: Self Esteem and Self Efficacy measured at baseline and 6 month follow-up Self-Esteem– (Rosenberg, 1965)– 10 item scale where participants are asked to respond to questions about themselves on a 4 point scale ranging from (0) strongly disagree to (3) strongly agree Chronbach’s alpha =.82; range Example: “I feel that I have a number of good qualities” Self Efficacy– HIV/HCV– 2 item scale- self report of self efficacy related to prevention of HIV/HCV infection; range from 0= low self efficacy to 6= high self efficacy; Chronbach’s alpha=.74. Example: “How much can you do to keep from getting HIV/AID?” and “How much can you do to keep from getting Hepatitis C?”

Results: Of the 228 participants interviewed at baseline, 7 were deceased at 6 month follow-up, 28 were re-incarcerated and 34 were lost to follow-up. With the exception of gender there were no differences in the demographics of participants completing only baseline data and those completing both baseline and 6 month follow-up (Table 1). Similarly there were no differences in baseline and 6 month participant characteristics across intervention arms (Table 2).

CharacteristicBaseline 6 monthstatistic (N=69) (N=159) Mean Age t=.774 Mean # incarcerations t=.007 Mean age 1 st injection t=.045 Mean times in drug Tx t=1.41 Mean mo. Income $ $ t=.618 Male64(92.8%) 159(100%)x 2 =11.78 Single never married 48(69.6%) 126(79.2%)x 2 =4.71 < High School41(59%) 110(69%)x 2 =4.89 Homeless12(17.4%) 36(22.6%)x 2 =.798 HCV+46(67.6%) 109(69.4%)x 2 =.070 HBV+ 1(1.5%) 9(5.7%)x 2 =++ p< Chi square not computed due to cell count less than 5 Table 1 Comparison of Participants who completed 6 month follow-up and those who completed only baseline interviews

CharacteristicOnly Baseline 6 monthstatistic (N=69) (N=159) Intervention Arm Control 24(34.8%)65(40.9%) x 2 =.07 PSP31(44.9%)62(39.0%) x 2 =.07 CCBI14(20.3%)32(20.1%) x 2 =.07 p< Chi square not computed due to cell count less than 5 Table 1 (cont.) Comparison of Participants who completed 6 month follow- up and those who completed only baseline interviews

Characteristic CT PCP CCBIstatistic (N=65) (N=62) (N=32) Mean Age f=1.14 Mean # incarcerations f=1.26 Mean age 1 st injection f=1.91 Mean times in drug Tx f=1.41 Mean mo. Income $ $ $ f=2.58 Male65(92.8%) 62(100%) 32(100%)x 2 =na Single never married 46(70.8%) 51(82.3%) 29(90,6%)x 2 =5.70 < High School44(67.7%) 44(71.0%) 22(68.8%)x 2 =.163 Homeless17(26.2%) 11(17.7%) 8 (25%)x 2 =1.41 HCV+47(74.6%) 42(67.7%) 20 (62.5%)x 2 =1.60 HBV+ 4(6.3%) 4(6.5%) 1 (3.1%)x 2 =++ ++ Chi square not computed due to cell count less than 5 Table 2 Descriptive characteristics by intervention arm at follow-up

Characteristic CT PCP CCBI statistic Shared Syringes baseline28(43.0%) 29(47.0%) 15(47.0%) x 2 =4.64 6mo follow up11(17.0%) 9(15.0%) 9(28.0%) x 2 =2.91 Shared Cookers baseline 29(44.6%) 34(54.8%) 15(46.9%) x 2 =1.40 6mo follow up 16(25.0%) 21(34.0%) 6(19.0%) x 2 =3.76 Shared Rinse Water baseline 27(41.5%) 28(45.2%) 16(50.0%) x 2 =.632 6mo follow up 12(18.0%) 16(26.0%) 6(19.0%) x 2 =.539 Shared Cotton baseline 26(40.0%) 28(45.2%) 13(40.6%) x 2 =.384 6mo follow up 14(22.0%) 15(24.0%) 6(19.0%) x 2 =.539 Backloaded baseline 18(27.7%) 23(37.1%) 9(28.1%) x 2 =1.51 6mo follow up 7(11.0%) 10(16.0%) 8(25.0%) x 2 =3.21 Mean Injection Risk Score baseline f= month follow-up f=.311 Table 3 High Risk Injection Practices at baseline and 6 month follow- up by intervention arm

High Risk Injection Practices As Table 3 demonstrates, all participants significantly reduced their high risk injecting practices Changes in high risk injecting practices were equivocal across intervention arms

Characteristic CT PCP CCBI statistic (N=65) (N=62) (N=32) Plan not to share needles in future baseline 62(95.4%) 62(100%) 32(100%) x 2 = mo follow up 61(93.8%) 61(98.4%) 31(96.9%) x 2 =.972 Plan to use pharmacies to purchase syringes baseline 8(12.3%) 17(27.4%) 5(15.6%) x 2 =15.74* 6mo follow up 24(36.9%) 25(40.3%) 12(37.5%) x 2 =1.41 Plan to use condoms in the future baseline47(72.3%) 46(74.2%) 25(78.1%) x 2 = month follow-up42(64.6%) 39(62.9%) 20(62.5%) x 2 =.725 Table 4 Readiness to change risk behavior at baseline and 6 month follow-up by intervention arm

Characteristic CT PCP CCBI statistic Mean Self Esteem Score baseline f=.220 6mo follow up f=.876 Mean HIV/HCV Self Efficacy Score baseline f= mo follow up f=1.564 Table 4 Self Esteem, and HIV/HCV Self Efficacy by Intervention Arm Assignment

Correlations Among Self Esteem, HIV/HCV Self Efficacy HIV/HCV Risk Behavior and Readiness to Change Risk Behavior Self esteem and HIV/HCV self efficacy are significantly positively correlated at both baseline and six-month follow-up (r=.23 p<.01; r=.43 p<.01) Self esteem is significantly inversely correlated to injection risk behavior scores at 6 month follow-up (r=.24 p<.01) Self esteem is significantly positively correlated with intention to not share syringes (r=.20 p<.05), intention to use pharmacies to purchase syringes (r=.21 p<.01) but not to intention to use condoms (r=.15 p=ns)

Conclusions: The findings from this study support our clinical experiences with IDUs seeking substance abuse treatment and strongly suggest that increasing self-esteem and self efficacy can both promote recovery and reduce HIV/HCV related high risk behaviors. Therefore, employing HIV/HCV interventions that increase self-esteem and self- efficacy are likely to result in significant reduction of HIV and HCV high risk injecting practices and should be incorporated into risk reduction programs targeting young injecting populations.